Goldman Sachs Group Inc Omeros Corp Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Omeros Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 181,155 shares of OMER stock, worth $644,911. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,155
Previous 181,155 -0.0%
Holding current value
$644,911
Previous $1.49 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$7.04 - $11.21 $214,332 - $341,288
-30,445 Reduced 14.39%
181,155 $1.49 Million
Q4 2024

Feb 11, 2025
BUY
$3.77 - $12.15 $126,068 - $406,296
33,440 Added 18.77%
211,600 $2.09 Million
Q3 2024

Nov 14, 2024
BUY
$3.54 - $5.47 $310,295 - $479,467
87,654 Added 96.85%
178,160 $707,000
Q2 2024

Aug 13, 2024
BUY
$3.04 - $4.23 $129,665 - $180,422
42,653 Added 89.13%
90,506 $367,000
Q1 2024

May 15, 2024
BUY
$2.88 - $4.89 $17,268 - $29,320
5,996 Added 14.32%
47,853 $165,000
Q4 2023

Feb 13, 2024
SELL
$1.08 - $3.63 $69,816 - $234,661
-64,645 Reduced 60.7%
41,857 $136,000
Q3 2023

May 14, 2024
BUY
$2.81 - $5.69 $181,652 - $367,830
64,645 Added 154.44%
106,502 $310,000
Q3 2023

Nov 14, 2023
SELL
$2.81 - $5.69 $94,463 - $191,280
-33,617 Reduced 23.99%
106,502 $310,000
Q2 2023

May 14, 2024
SELL
$4.45 - $7.57 $440,171 - $748,786
-98,915 Reduced 41.38%
140,119 $762,000
Q2 2023

Aug 14, 2023
SELL
$4.45 - $7.57 $440,171 - $748,786
-98,915 Reduced 41.38%
140,119 $762,000
Q1 2023

May 14, 2024
BUY
$2.48 - $5.22 $531,947 - $1.12 Million
214,495 Added 874.1%
239,034 $1.11 Million
Q1 2023

May 11, 2023
BUY
$2.48 - $5.22 $531,947 - $1.12 Million
214,495 Added 874.1%
239,034 $1.11 Million
Q4 2022

May 14, 2024
BUY
$1.75 - $3.96 $8,130 - $18,398
4,646 Added 23.35%
24,539 $55,000
Q4 2022

Feb 13, 2023
BUY
$1.75 - $3.96 $8,130 - $18,398
4,646 Added 23.35%
24,539 $55,000
Q3 2022

May 14, 2024
SELL
$3.09 - $7.46 $284,320 - $686,416
-92,013 Reduced 82.22%
19,893 $63,000
Q3 2022

Nov 10, 2022
SELL
$3.09 - $7.46 $284,320 - $686,416
-92,013 Reduced 82.22%
19,893 $62,000
Q2 2022

May 14, 2024
BUY
$1.92 - $6.28 $134,494 - $439,907
70,049 Added 167.35%
111,906 $308,000
Q2 2022

Aug 15, 2022
SELL
$1.92 - $6.28 $169,591 - $554,706
-88,329 Reduced 44.11%
111,906 $308,000
Q1 2022

May 16, 2022
SELL
$5.07 - $7.2 $20,538 - $29,167
-4,051 Reduced 1.98%
200,235 $1.2 Million
Q4 2021

Feb 14, 2022
SELL
$5.67 - $8.54 $568,071 - $855,614
-100,189 Reduced 32.91%
204,286 $1.31 Million
Q3 2021

Nov 10, 2021
BUY
$13.4 - $16.3 $4.08 Million - $4.96 Million
304,475 New
304,475 $4.2 Million

Others Institutions Holding OMER

# of Institutions
153
Shares Held
28M
Call Options Held
369K
Put Options Held
697K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $223M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email